Brief: Crossject H1 Operating Loss Widens To 5.7 Million Euros
Sept 9 (Reuters) - CROSSJECT SA ALCJ.PA :
* H1 NET LOSS OF EUR 5.0 MILLION VERSUS LOSS OF EUR 4.7 MILLION YEAR AGO
* H1 OPERATING LOSS OF EUR 5.7 MILLION VERSUS LOSS OF EUR 5.3 MILLION YEAR AGO
* H1 OPERATING REVENUE EUR 1.8 MILLION VERSUS EUR 2.8 MILLION YEAR AGO
Source text for Eikon: ID:nGNE4y62fz
Further company coverage: ALCJ.PA
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Crossject SA
See all newsBrief: Crossject Says Expects To File For EUA Early Next Year For Epilepsy Rescue Therapy Zepizure
Brief: Crossject Signs A Geographic Extension Of Zepizure Commercialization Agreement In Europe
Brief: Crossject FY Operating Income Up At EUR 12.82 Mln
Brief: Crossject Announces Contract Of Up To $155 Mln With BARDA
Brief: Crossject Engages Syneos Health For U.S. Commercial Launch Of Zepizure